Shkreli's Turing Pharmaceuticals raised the price of an anti-parasitic drug from $13.50 to over $750 overnight, sparking ...

Tyr Pharma (ATYR) shares remain in focus on Thursday after controversial American investor Martin Shkreli revealed a short ...

Martin Shkreli, known for once hiking the price of a life-saving drug more than 4,000%, cannot return to the pharmaceutical industry after a federal appeals court on Tuesday upheld his lifetime ban.

A federal judge on Friday banned the controversial former pharmaceutical executive Martin Shkreli from ever working in that industry again and ordered him to return $64.6 million in wrongfully ...

Convicted “Pharma Bro” Martin Shkreli has finally been ousted as boss of the pharmaceutical company he founded, The Post has learned. Activist shareholders booted the group of directors still ...

Convicted pharmaceutical fraudster Martin Shkreli, known publicly as “Pharma Bro,” was released from prison on Wednesday, and will spend the rest of his sentence in a halfway house.

Martin Shkreli, the former pharmaceutical executive known for raising the price of a lifesaving drug more than 40-fold, has been released from prison, where he had been serving a seven-year term ...

Shkreli's father was also present for the reading of the verdict. Former drug company executive Martin Shkreli exits the U.S. District Court in Brooklyn, New York, July 28, 2017.

Martin Shkreli’s long, strange tale could end with a decade in prison A courtroom sketch shows former Martin Shkreli, left, seated next to defense lawyer Ben Brafman on Feb. 23 in New York.

Shkreli, who gained notoriety as the “Pharma Bro” executive who raised the price of an AIDS drug by 5,000 percent, has been serving a seven-year sentence at a low-security prison in Allenwood ...

Martin Shkreli’s journey from pharma exec to inmate No. 87850-053 » Less than a year later, the U.S. indicted him, accusing Shkreli of running his funds like Ponzi schemes.

Shkreli is best known for increasing the price of a life-saving drug for people with AIDS by 5,000 percent, from $13.50 to $750 per pill, when he was head of Turing Pharmaceuticals.